Hovione Launches ASD-HIPROS
The Most Advanced Screening Service for Optimal Spray Dried Dispersions Formulation
The Most Advanced Screening Service for Optimal Spray Dried Dispersions Formulation
Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®
Effective May 1st, 2020
Hovione announced details of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development program for the treatment of moderate to severe inflammatory rosacea.
Loughbeg, Co. Cork. Thursday, September 5th, 2019: Hovione is celebrating its 60th Anniversary today in its site in Cork.
Hovione has issued a bond of $50 million US dollars maturing in 2033.
‘One Site Shop’ expands to respond to growing demands
Hovione reported today recent capacity expansion and future plans in its sites in Portugal, Ireland and New Jersey.
Hovione announced today that in the last year their manufacturing facilities were the object of eight inspections, performed by different Health Authorities.